GRP78 expressed on the tumor cell surface contributes to the pathogenesis of breast cancer (see Section 4.2.2) and appears to be a very appropriate target for selective attacking with GRP78-recognizing immunoglobulins. The gene discussed is HSPA5; the disease is breast cancer.